Investigator Initiated Study for the Safety and Efficacy in Frontotemporal Dementia

NCT07154485 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

15

Enrollment

OTHER

Sponsor class

Conditions

Dementia Frontotemporal

Interventions

DRUG: NS101 IV infusion
DRUG: Placebo IV Infusion

Sponsor

Hee-Jin Kim

Collaborators

[object Object]
[object Object]
[object Object]